Guttate Psoriasis clinical trials at UCSF

1 research study open to eligible people

Guttate psoriasis is a type of psoriasis with small, drop-shaped red bumps on the skin. UCSF is studying how guselkumab affects symptoms in people with plaque or guttate psoriasis. UCSF is collecting clinical and immune system data to compare responses.

Showing trials for

  • Guselkumab Immunogenetics

    open to eligible people ages 18 years and up

    This is a two-arm open-label study to evaluate the clinical and immunogenetic responses of patients with plaque or guttate psoriasis to treatment with guselkumab.

    San Francisco, California

Our lead scientists for Guttate Psoriasis research studies include .

Last updated: